Oxford vaccine producing immune response in old and young adults, says UK firm

The pharmaceutical industry said that the vaccine caused lower adverse effects among the elderly as well. On Monday, United Kingdom-based pharmaceutical company AstraZeneca said that the coronavirus vaccine being developed by Oxford University induces an immune response, Reuters said, in both old and young adults.

The vaccine, the pharmaceutical company said, also causes lower adverse reactions among the elderly. "It is reassuring to see that immunogenicity responses were comparable among older and younger adults and that in older adults, where the incidence of Covid-19 disease is greater, reactogenicity [referring to common side effects of vaccines] was lower," said an AstraZeneca spokesperson. The body of evidence for the safety and immunogenicity of AZD1222 [the technical name of the vaccine] is further established by the findings.\'

According to The Financial Times, the statement is critical as age is considered a primary factor in developing a Covid-19 vaccine. Analysis has been motivated by the discovery that the AstraZeneca vaccine can activate T-body cells and antibodies, as they are hoping for a cure that does not result in severe elderly diseases or fatalities.

However, the pharmaceutical firm did not provide specifics of the results. It also did not say when the findings of the Phase 3 tests that illustrate the effectiveness of the vaccine will be released in large-scale studies to be accepted.

Jonathan Ball, a virology professor at the University of Nottingham, called the arguments made by the pharmaceutical firm a positive sign. The professor, however, said that understanding if the vaccine protects against severe illnesses was important.

The findings of the phase 1 and 2 Oxford vaccine trials published in the scientific journal The Lancet in July revealed that there were no early safety issues with the vaccine and that both parts of the immune system produced \'solid immune responses\'.

"The vaccine triggered a response of T cells within 14 days of vaccination (white blood cells that are capable of destroying SARS-CoV-2 virus-infected cells) and an antibody response within 28 days (antibodies are capable of neutralizing the virus so that when initially contracted, it does not infect cells)," the University of Oxford said in a statement.

According to Johns Hopkins University, the coronavirus has infected more than 4.29 crore individuals globally and killed 11,52,978. Recoveries worldwide surpassed 2.88 crores.

ThankYou!